Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung Cancer
Clinical trial NCT00705549 · TERMINATED
Trial details
- NCT number
- NCT00705549
- Sponsor
- Hellenic Oncology Research Group
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2011-09-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.